Fingerprint
Dive into the research topics of 'A PD-L1 aptamer selected by loss-gain cell-SELEX conjugated with paclitaxel for treating triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by:
- Weight
- Alphabetically
A PD-L1 aptamer selected by loss-gain cell-SELEX conjugated with paclitaxel for treating triple-negative breast cancer
Xiaoqiu Wu, Fangfei Li*, Yongshu Li, Yuanyuan Yu, Chao Liang, Baoting Zhang, Chuanzong Zhao, Aiping Lu*, Ge Zhang*
*Corresponding author for this work
Research output: Contribution to journal › Journal article › peer-review
26
Citations
(Scopus)